Mouse Rnasek/2310033H11Rik/AA571397 ORF/cDNA clone-Adeno-associate virus(AAV) plasmid (NM_173742.3)

Cat. No.: pGMAAV000560
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Mouse Rnasek/2310033H11Rik/AA571397 Adeno-associated virus expression plasmid (ITR-vector) for Rnasek AAV packaging, Rnasek AAV production.The purified Mouse Rnasek/2310033H11Rik/AA571397 AAV particle serves as an invaluable asset for in-depth in vivo Rnasek studies, mechanism of action (MOA) research, and the evolution of Rnasek-associated gene therapy strategies.

Our GM-AAV ITR vector is optimized with the G-NEXT™ multi-serotypes AAV vector system. Explore the G-NEXT™ system in detail.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Purchase
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMAAV000560
Gene Name Rnasek
Accession Number NM_173742.3
Gene ID 52898
Species Mouse
Product Type Adeno-associate virus(AAV) plasmid (overexpression)
Insert Length 297 bp
Gene Alias 2310033H11Rik,AA571397,D11Bwg0434e
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGCGTCGCTCCTGTGCTGTGGGCCTAAGCTGGCCGCCTGTGGCATCGTCCTCAGCGCCTGGGGAGTGATCATGTTGATAATGCTCGGGATATTTTTCAATGTCCATTCTGCTGTGTTAATTGAGGACGTTCCCTTCACAGAGAAAGATTTTGAGAACGGTCCTCAGAACATATACAACCTGTACGAGCAAGTCAGCTACAACTGTTTCATCGCCGCGGGCCTCTACCTCCTCCTCGGAGGCTTCTCCTTCTGCCAAGTTCGTCTCAACAAGCGCAAGGAATACATGGTGCGCTAG
ORF Protein Sequence MASLLCCGPKLAACGIVLSAWGVIMLIMLGIFFNVHSAVLIEDVPFTEKDFENGPQNIYNLYEQVSYNCFIAAGLYLLLGGFSFCQVRLNKRKEYMVR

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    ORF Viral Vector vGMAAV000560 Mouse Rnasek Adeno-associate virus(AAV) particle




    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.